A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye

Innovative Medical

Status and phase: Completed; Phase 4

Conditions: Dry Eye

Treatments: Drug: Optive

Study type: Interventional

Funder types: Industry

Identifiers

NCT00399230

5279

Details and patient eligibility

About

To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• · Dry eye disease diagnosis

  • Patients must currently be using Systane tears at least once a day and for at least 1 month.
  • Normal lid position and closure
  • Male or female of legal age of consent
  • Informed consent has been obtained
  • Likely to complete all required follow-up visits

Exclusion criteria

• · Concurrent enrollment in an investigational drug or device study, or participation in such a study within 30 days of entry into this study.

  • Subject has a condition, or is in a situation which, in the investigator's opinion, may put the subject at a significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.